business

Sandoz warns that low-cost Chinese imports jeopardize Europe's antibiotic supply

31 Mayıs 2026Financial Times

Sandoz has raised alarms about the potential threat posed by inexpensive Chinese imports to Europe's antibiotic supply. The company's chief executive emphasized that without stronger protections, the continent may face a significant loss of critical medicine capacity.
This situation calls for urgent attention to safeguard the pharmaceutical landscape in Europe.
The issue of antibiotic supply has been exacerbated by the COVID-19 pandemic, which disrupted global supply chains and highlighted the risks of dependence on foreign production. With rising concerns about antibiotic resistance, maintaining a robust supply of these medications is crucial for healthcare systems across…
The warning from Sandoz highlights a growing concern within the pharmaceutical industry regarding the reliance on low-cost imports for essential medicines. As global supply chains become increasingly interconnected, the vulnerability of local production capabilities is brought to the forefront.

NewsAI özeti

This summary is based on information from the Financial Times and may not reflect the latest developments.

Tam teknik rapor ve canlı veriler için yayıncının web sitesini ziyaret edin.

Her yerde okuyun. iOS ve Android için ödüllü uygulamalarımızı indirin.